GHRSGH Research PLC Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 15982
Ticker: GHRS
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-06-25
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: GHRS

Detail

Enriched 2026-08-14 20:47

Market cap: $2,075,742,758.88
Shares outstanding (class): 68,608,919
Shares outstanding (weighted): 68,642,287
SIC: —
Employees: 73
Location: —
Homepage: https://www.ghres.com
Description: GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Market cap and share counts drift.

Funds holding this security

7 funds · 7 positions · $6.22M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Biotechnology ETF iShares Trust	IBB	$4.70M	0.06%	334,162 NS	TICKER
AdvisorShares Psychedelics ETF AdvisorShares Trust	PSIL	$942.5K	4.65%	67,034 NS	TICKER
TIFF MULTI-ASSET FUND TIFF Investment Program	—	$338.5K	0.02%	24,077 NS	TICKER
State Street(R) SPDR(R) S&P(R) International Sm… SPDR INDEX SHARES FUNDS	GWX	$155.3K	0.02%	11,049 NS	TICKER
Small Cap Core Fund Northern Funds	—	$88.0K	0.03%	6,256 NS	TICKER
First Trust IPOX Europe Equity Opportunities ETF First Trust Exchange-Traded Fund II	FPXE	$1.7K	0.04%	118 NS	TICKER
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	-$4.2K	-0.00%	-300 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERGHRS
CIK0001855129
ISINIE000GID8VI0
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: GH Research is a clinical-stage biopharmaceutical company developing psychedelic-based therapies for psychiatric disorders.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.